InMed Pharmaceuticals Inc share price logo

InMed Pharmaceuticals Inc

NASDAQ: INM

Small Cap

$0.75

+0.02

(+2.77%)

Live

as on

InMed Pharmaceuticals Inc Stock Performance

as on May 8, 2026 at 1:12 am IST

  • Day's Low

    Day's High

    $0.70
    $0.79
    downward going graph

    6.67%

    Downside

    5.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.58
    $7.98
    downward going graph

    23.33%

    Downside

    964.00%

    Upside

    downward going graph

InMed Pharmaceuticals Inc share price movements today

Previous Close
$0.73
Open
$0.73
Volume
41.9K
Day's Low - High
$0.70 - $0.79
52 Week Low - High
$0.58 - $7.98

InMed Pharmaceuticals Inc Historical Returns

1 Month Return
+ 6.76 %
3 Month Return
-22.75 %
1 Year Return
-73.45 %
3 Year Return
-97.05 %
5 Year Return
-99.96 %

InMed Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check InMed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.6M

Revenue (TTM)

4.5M

Profit Margin

-170.07%

Return On Equity TTM

-97.20%

InMed Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of InMed Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$2.5M-99.96%NA-170.07%
BUY$25.3BNA21.4141.94%
HOLD$18.1B13.28%NA-24.58%
BUY$41.0BNA18.4615.11%
BUY$46.9B-35.17%18.4828.24%

Stock Returns calculator for InMed Pharmaceuticals Inc Stock including INR - Dollar returns

The InMed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

InMed Pharmaceuticals Inc investment value today

Current value as on today

₹30,448

Returns

-₹69,552

(-69.55%)

Returns from InMed Pharmaceuticals Inc Stock

-₹72,628 (-72.63%)

Dollar Impact

₹3,075 (+3.08%)

Analyst Recommendation on InMed Pharmaceuticals Inc Stock

Based on 8 analysts

SELL

0.00%

Buy

37.50%

Hold

62.50%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for InMed Pharmaceuticals Inc. Average target price of $20

InMed Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on InMed Pharmaceuticals Inc.

What analysts predicted

96.25%UPSIDE

Target Price

$20

Current Price

$0.75

Analyzed by

8 Analysts

Target

$20.00

InMed Pharmaceuticals Inc target price $20, a slight upside of 96.25% compared to current price of $0.75. According to 8 analysts rating.

Indian Investors' Interest in InMed Pharmaceuticals Inc Stock

Search interest for InMed Pharmaceuticals Inc Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:4% versus previous 30 day period

InMed Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
1
1
1
1
1
659
Gross Profit
0
0
0
0
0
0
0
0
0
66
Operating Income
-1
-1
-2
-1
-2
-2
-2
-1
-2
-174
EBITDA
-1
-1
-1
-1
-2
-1
-2
-1
-2
-173
Interest Expense
-
-
-
-
0
-
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-1
-1
-1
-1
-2
-2
-2
-1
-2
-174
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-1
-1
-1
-1
-2
-2
-2
-1
-2
-174
Net Profit Margin
-119.19%
-146.93%
-151.02%
-132.68%
-231.63%
-168.12%
-137.07%
-154.17%
-247.29%
-26.46%

InMed Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
0
3
3
4
Gross Profit
-
0
0
0
0
0
1
0
1
Operating Income
-3
-6
-10
-9
-12
-13
-8
-8
-7
EBITDA
-3
-6
-10
-8
-12
-13
-7
-7
-7
Interest Expense
0
0
0
0
0
0
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-6
-10
-8
-12
-18
-7
-7
-8
Income Tax Expense
0
0
0
0
0
4
0
0
-
Net Income
-2
-5
-7
-6
-10
-14
-5
-5
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-1707.32%
-192.18%
-166.94%
-165.14%

InMed Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
-1
-1
-2
-2
-1
-2
-3,753
-2,965
Operating Cash Flow
-1
-1
-1
-2
-1
-1
-2
-3
-5,673
Investing Cash Flow
0
0
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
2
8
0
0
94
Change in Cash
-1
-1
0
-2
1
6
-2
-3
5,149

InMed Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-3
-6
-10
-8
-10
-18
-7
-7
-8
Operating Cash Flow
-2
-3
-6
-7
-9
-15
-7
-6
-7
Investing Cash Flow
0
-1
-2
3
0
0
0
0
-
Financing Cash Flow
7
19
0
0
10
15
10
4
12
Change in Cash
5
13
-8
-4
1
-1
2
-2
4

Global Institutional Holdings in InMed Pharmaceuticals Inc

Funds
Holdings
Sabby Management LLC
6.08%
Banque Cantonale Vaudoise
0%
Jane Street Group LLC
0.36%
SBI Securities Co Ltd
0.01%
Tower Research Capital LLC
0%

Insights on InMed Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 21.76% to 26.20% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.12M → 659.84M (in $), with an average increase of 50.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, INM stock has moved up by 8.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 178.7% return, outperforming this stock by 275.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 94.4% return, outperforming this stock by 167.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.72M → -174.58M (in $), with an average decrease of 3117.2% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.99% to 5.26% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 70.26% to 68.54% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, INM stock has moved down by -54.6%

About InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
OrganisationInMed Pharmaceuticals Inc
Headquarters885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Eric A. Adams B.S. Chem., M.I.B.
E-voting on sharesClick here to vote

Key Management of InMed Pharmaceuticals Inc

Name

Title

Dr. Eric Chih-Hsien Hsu Ph.D.

Senior Vice President of Preclinical Research & Development

Dr. Sazzad Hossain M.Sc., Ph.D.

Co-Founder

Colin Clancy

Senior Director of Investor Relations

Mr. Jerry P. Griffin

Vice President of Sales & Marketing

Dr. Shane A. Johnson Ph.D.

Senior VP & GM of BayMedica

Mr. Eric A. Adams B.S. Chem., M.I.B.

President, CEO & Director

Ms. N. Netta Jagpal

CFO & Corporate Secretary

Mr. Michael Woudenberg P.Eng.

Chief Operating Officer

FAQs

What is InMed Pharmaceuticals Inc share price today?

InMed Pharmaceuticals Inc share price today is $0.75 as on . InMed Pharmaceuticals Inc share today touched a day high of $0.79 and a low of $0.7.

What is the 52 week high and 52 week low for InMed Pharmaceuticals Inc share?

InMed Pharmaceuticals Inc share touched a 52 week high of $7.98 on and a 52 week low of $0.58 on . InMed Pharmaceuticals Inc stock price today i.e. is trending at $0.75,which is 90.60% down from its 52 week high and 30.43% up from its 52 week low.

What is InMed Pharmaceuticals Inc's market capitalisation today?

InMed Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in InMed Pharmaceuticals Inc Stock (INM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for InMed Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in InMed Pharmaceuticals Inc Shares that will get you 2.0000 shares as per InMed Pharmaceuticals Inc share price of $0.75 per share as on May 7, 2026 at 7:42 pm IST.

What is the minimum amount required to buy InMed Pharmaceuticals Inc Stock (INM) from India?

Indian investors can start investing in InMed Pharmaceuticals Inc (INM) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in InMed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on InMed Pharmaceuticals Inc share’s latest price of $0.75 as on May 7, 2026 at 7:42 pm IST, you will get 13.3333 shares of InMed Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that InMed Pharmaceuticals Inc has given to Indian investors in the last 5 years?

InMed Pharmaceuticals Inc stock has given -99.96% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?